Edition:
United Kingdom

Moleculin Biotech Inc (MBRX.OQ)

MBRX.OQ on NASDAQ Stock Exchange Capital Market

1.36USD
15 Oct 2018
Change (% chg)

-- (--)
Prev Close
$1.36
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
29,277
52-wk High
$3.33
52-wk Low
$1.31

Chart for

About

Moleculin Biotech, Inc. is a preclinical-stage pharmaceutical company. The Company is focused on the development of anti-cancer drug candidates. Its lead drug candidate is liposomal Annamycin, which it refers to as Annamycin, an anthracycline intended for the treatment of relapsed or refractory acute myeloid leukemia (AML).... (more)

Overall

Beta: --
Market Cap(Mil.): $49.84
Shares Outstanding(Mil.): 20.26
Dividend: --
Yield (%): --

Financials

  MBRX.OQ Industry Sector
P/E (TTM): -- 30.95 32.69
EPS (TTM): -0.46 -- --
ROI: -35.48 14.77 14.32
ROE: -36.21 16.27 16.04

Earnings vs. Estimates